Fewer but heavier caffeine consumers in schizophrenia: A case-control study

Schizophrenia Research

Volumn 86, Issue 1-3, 2006, Pages 276-283

  Gurpegui, Manuel ^a   Aguilar, M Carmen ^a   Martínez Ortega, José M ^a   Jurado, Dolores ^a   Diaz, Francisco J ^b   Quintana, Hernando M ^c   de Leon, Jose ^a,d  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c INSTITUTO TECNOLÓGICO METROPOLITANO   (Colombia)

^d EASTERN STATE HOSPITAL   (United States)

Author keywords

Alcohol; Caffeine; Case control study; Coffee; Nicotine; Schizophrenia; Tobacco smoking

Indexed keywords

ALCOHOL; CAFFEINE; CYTOCHROME P450 1A2; NICOTINE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PUBLICATION; SCHIZOPHRENIA; SMOKING; STATISTICAL SIGNIFICANCE; TOBACCO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; CAFFEINE; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; DRINKING BEHAVIOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33747164489     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.04.022     Document Type: Article

References (34)

1. Aguilar M.C., Gurpegui M., Diaz F.J., and de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br. J. Psychiatry 186 (2005) 215-221
2. Amit Z., Weiss S., Smith B.R., and Markevitch S. Use of caffeine-based products and tobacco in relation to the consumption of alcohol. An examination of putative relationships in a group of alcoholics in Israel. Eur. Addict. Res. 10 (2004) 22-28
3. Barone J.J., and Roberts H.R. Caffeine consumption. Food Chem. Toxicol. 34 (1996) 119-129
4. Broderick P., and Benjamin A.B. Caffeine and psychiatric symptoms: a review. J. Okla. State Med. Assoc. 97 (2004) 538-542
5. Daily J.W., and Fredholm B.B. Caffeine: an atypical drug of dependence. Drug Alcohol Depend. 51 (1998) 199-206
6. de Leon J., and Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76 (2005) 135-157
7. de Leon J., Diaz F.J., Rogers T., Browne D., Dinsmore L., Ghosheh O., Dwoskin L.P., and Crooks P. A pilot study of plasma caffeine concentrations in a US sample of smoker and non-smoker volunteers. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 (2003) 165-171
8. Dervaux A., Baylé J.F., Laqueille X., Bourdel M.C., Le Borgne M.H., Olié J.P., and Krebs M.O. Nicotine use and disinhibition. Psychiatry Res. 128 (2004) 229-234
9. Dixon D.A., Fenix L.A., Kim D.M., and Raffa R.B. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists. Ann. Pharmacother. 33 (1999) 480-488
10. Donovan J.L., and De Vane C.L. A primer on caffeine pharmacology and its drug interactions in clinical psychopharmacology. Psychopharmacol. Bull. 35 (2001) 30-48
11. Etter M., and Etter J.F. Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population. Schizophr. Bull. 30 (2004) 947-956
12. Ferré S. Adenosine-dopamine interactions in the ventral striatum: implications for the treatment of schizophrenia. Psychopharmacology 133 (1997) 107-120
13. Goldberg D.P., and Hillier V.F. A scaled version of the General Health Questionnaire. Psychol. Med. 9 (1979) 139-145
14. Gurpegui M., Aguilar M.C., Martínez-Ortega J.M., Diaz F.J., and de Leon J. Caffeine intake in outpatients with schizophrenia. Schizophr. Bull. 30 (2004) 935-945
15. Gurpegui M., Martínez-Ortega J.M., Aguilar M.C., Diaz F.J., Quintana H.M., and de Leon J. Smoking initiation and schizophrenia: a replication study in a Spanish sample. Schizophr. Res. 76 (2005) 113-118
16. Gut-Fayand A., Dervaux A., Olié J.P., Lôo H., Poirier M.F., and Krebs M.O. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res. 102 (2001) 65-72
17. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerström K.O. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br. J. Addict. 86 (1991) 1119-1127
18. Hettema J.M., Corey L.A., and Kendler K.S. A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. Drug Alcohol Depend. 57 (1999) 69-78
19. Hosmer D.W., and Lemeshow S. Applied Logistic Regression. 2nd ed (2000), John Wiley & Sons Inc, New York
20. Hughes J.R. What alcohol/drug abuse clinicians need to know about caffeine. Am. J. Addict. 5 (1996) 49-57
21. Hughes J.R., McHugh P., and Holtzman S. Caffeine and schizophrenia. Psychiatr. Serv. 49 (1998) 1415-1417
22. Istvan J., and Matarazzo J.D. Tobacco, alcohol and caffeine use: a review of their interrelationships. Psychol. Bull. 95 (1984) 301-326
23. Lobo A., Pérez-Echeverría M.J., and Artal J. Validity of the scaled version of the General Health Questionnaire (GHQ 28) in a Spanish population. Psychol. Med. 16 (1986) 135-140
24. Lorist M.M., and Tops M. Caffeine, fatigue, and cognition. Brain Cogn. 53 (2003) 82-94
25. Lucas P.B., Pickar D., Kelsoe J., Rapaport M., Pato C., and Hommer D. Effects of the acute administration of caffeine in patients with schizophrenia. Biol. Psychiatry 28 (1990) 35-40
26. Martín Pérez C., Pedrosa Garcia R., Herrero Martin J.J., Luna del Castillo J.D., Ramirez Garcia P., and Saez Garcia J.M. Prevalence of psychiatric pathology at a rural health centre. Aten. Prim. 31 (2003) 39-46 (in Spanish)
27. Martínez-Ortega, J.M., Jurado, D., Martínez-González, M.A., Gurpegui, M., in press. Nicotine dependence, use of illegal drugs and psychiatric morbidity. Addict. Behav.
28. Missak S.S. Exploring the role of an endogenous caffeine-like substance in the pathogenesis of schizophrenia. Med. Hypotheses 36 (1991) 157-161
29. Pinilla J., and González B. Profile of the population of Spain with respect to the smoking habit, period 1993-1997. Eur. J. Public Health 11 (2001) 346-351
30. Shoaib M., Swanner L.S., Yasar S., and Goldberg S.R. Chronic caffeine exposure potentiates nicotine self-administration in rats. Psychopharmacology 142 (1999) 327-333
31. Schneier F.R., and Siris S.G. A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice. J. Nerv. Ment. Dis. 175 (1987) 641-652
32. Swanson J.A., Lee J.W., and Hopp J.W. Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict. Behav. 19 (1994) 229-256
33. Tanda G., and Goldberg S. Alteration of the behavioral effects of nicotine by chronic caffeine exposure. Pharmacol. Biochem. Behav. 66 (2000) 47-64
34. Woodward M. Epidemiology. Study Design and Data Analysis (1999), Chapman and Hall/CRC, Boca Raton